Cargando…

Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer that harbors enriched cancer stem cell (CSC) populations in tumors. Conventional chemotherapy is a standard treatment for TNBC, but it spares the CSC populations, which cause tumor recurrence and progression. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jiabei, Lee, Hong-Jen, Saha, Suchandrima, Ruan, Diane, Guo, Hua, Chan, Chia-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437220/ https://www.ncbi.nlm.nih.gov/pubmed/30918246 http://dx.doi.org/10.1038/s41419-019-1512-6

Ejemplares similares

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

Skp2 deficiency restricts the progression and stem cell features of castration-resistant prostate cancer by destabilizing Twist
por: Ruan, Diane, et al.
Publicado: (2017)

Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion
por: Lee, Hong-Jen, et al.
Publicado: (2019)

Tackling Cancer Stem Cells via Inhibition of EMT Transcription Factors
por: Mladinich, Megan, et al.
Publicado: (2016)

CDK5 Inhibition Abrogates TNBC Stem‐Cell Property and Enhances Anti‐PD‐1 Therapy
por: Bei, Yuncheng, et al.
Publicado: (2020)

Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes
por: Liu, Mengjie, et al.
Publicado: (2023)

HectH9 hijacks glucose metabolism to fuel tumor growth
por: Lee, Hong-Jen, et al.
Publicado: (2019)

Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
por: Ferrari, Paola, et al.
Publicado: (2022)

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
por: Sulaiman, Andrew, et al.
Publicado: (2021)

Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)
por: Hong, Jiaxin, et al.
Publicado: (2022)

Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC
por: Massa, Chiara, et al.
Publicado: (2020)

Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells
por: Sulaiman, Andrew, et al.
Publicado: (2020)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity
por: He, Yonghan, et al.
Publicado: (2020)

Post-Hypoxic Cells Promote Metastatic Recurrence after Chemotherapy Treatment in TNBC
por: Godet, Inês, et al.
Publicado: (2021)

Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide
por: Xia, Xiaohong, et al.
Publicado: (2019)

Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
por: Singh, Desh Deepak, et al.
Publicado: (2021)

Inhibition of ERK signaling for treatment of ERRα positive TNBC
por: Musheyev, David, et al.
Publicado: (2023)

A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis
por: Kim, Ji Hyeon, et al.
Publicado: (2023)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?
por: Cerbelli, Bruna, et al.
Publicado: (2017)

FZD5 contributes to TNBC proliferation, DNA damage repair and stemness
por: Sun, Yu, et al.
Publicado: (2020)

Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020)

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021)

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy
por: Luen, Stephen L., et al.
Publicado: (2019)

Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2021)

47982 Reversing the resistance to chemotherapy in White and Black patients with triple negative breast cancer (TNBC).
por: Gandhi, Shipra, et al.
Publicado: (2021)

Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress
por: Al Haq, Aushia Tanzih, et al.
Publicado: (2022)

Selective Inhibition of USP7
por: Menard, Robert, et al.
Publicado: (2012)

TNBC invasion: downstream of STAT3
por: Jackson, James G., et al.
Publicado: (2017)

Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach
por: Petrosyan, Varduhi, et al.
Publicado: (2022)

Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma
por: Li, Xi-Ya, et al.
Publicado: (2022)

The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC
por: Khera, Lohit, et al.
Publicado: (2021)

Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model
por: Reinitz, Felicia, et al.
Publicado: (2022)

USP48/USP31 Is a Nuclear Deubiquitinase that Potently Regulates Synapse Remodeling
por: Ma, Qi, et al.
Publicado: (2023)

USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress
por: Wu, Yueguang, et al.
Publicado: (2020)

The Potential of PSMA as a Vascular Target in TNBC
por: Heesch, Amelie, et al.
Publicado: (2023)

Aptamer-Based Strategies to Boost Immunotherapy in TNBC
por: Agnello, Lisa, et al.
Publicado: (2023)

Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
por: Chaudhuri, Aiswarya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dh1de57ig6t4da5lp431bublmc